BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$615M |
| 2 |
State Street SPDR S&P Retail ETF
XRT
|
+$231M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$229M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$186M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$620M |
| 3 |
Tesla
TSLA
|
+$594M |
| 4 |
Apple
AAPL
|
+$541M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.24% |
| 2 | Financials | 6.85% |
| 3 | Healthcare | 5.31% |
| 4 | Consumer Discretionary | 4.97% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICAD
3401
DELISTED
iCAD Inc
ICAD
| $44.3K | ﹤0.01% |
4,119
+3,148
| +324% | +$41K |
|
3402
Escalade
ESCA
$283M
| $44.2K | ﹤0.01% |
2,338
+1,619
| +225% | +$35.9K |
|
|
VOXX
3403
DELISTED
VOXX International Corporation Class A
VOXX
| $44.1K | ﹤0.01% |
3,854
+399
| +12% | +$4.56K |
|
3404
InfuSystem Holdings
INFU
$249M
| $44K | ﹤0.01% |
3,378
+2,732
| +423% | +$44.6K |
|
3405
Evolus
EOLS
$542M
| $43.5K | ﹤0.01% |
5,715
+4,375
| +326% | +$45.2K |
|
3406
Cemex
CX
$16B
| $43.1K | ﹤0.01% |
6,011
-949
| -14% | -$7.49K |
|
3407
AgEagle Aerial Systems
UAVS
$60.4M
| $43K | ﹤0.01% |
14
+11
| +367% | +$40.9K |
|
|
TRVN
3408
DELISTED
Trevena, Inc.
TRVN
| $42.9K | ﹤0.01% |
56
+46
| +460% | +$39K |
|
|
AXIA
3409
DELISTED
AXIA Energia
AXIA
| $42.9K | ﹤0.01% |
7,625
+5,327
| +232% | +$32.3K |
|
3410
Mustang Bio
MBIO
$4.55M
| $42.7K | ﹤0.01% |
21
+11
| +110% | +$23.6K |
|
3411
The ONE Group
STKS
$56.5M
| $42.5K | ﹤0.01% |
3,973
+3,220
| +428% | +$33.2K |
|
3412
CorMedix
CRMD
$648M
| $42.2K | ﹤0.01% |
9,066
+5,785
| +176% | +$33.7K |
|
|
ITI
3413
DELISTED
Iteris, Inc.
ITI
| $41.7K | ﹤0.01% |
7,903
+6,395
| +424% | +$37.4K |
|
|
SEEL
3414
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $41.7K | ﹤0.01% |
5
+4
| +400% | +$34.4K |
|
|
IMDX
3415
Insight Molecular Diagnostics
IMDX
$136M
| $40.1K | ﹤0.01% |
564
+441
| +359% | +$40.5K |
|
|
ENV
3416
PUT
DELISTED
ENVESTNET, INC.
ENV
| $40.1K | ﹤0.01% |
5
-195
| -98% | -$14.9K |
|
3417
Fortress Biotech
FBIO
$92.7M
| $40.1K | ﹤0.01% |
831
+633
| +320% | +$30.9K |
|
|
EVLO
3418
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $40.1K | ﹤0.01% |
285
+247
| +650% | +$48.9K |
|
|
PZN
3419
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $40.1K | ﹤0.01% |
4,072
+3,400
| +506% | +$36.4K |
|
3420
KVH Industries
KVHI
$145M
| $39.9K | ﹤0.01% |
4,144
+2,261
| +120% | +$24.5K |
|
3421
Dianthus Therapeutics
DNTH
$6.21B
| $39.8K | ﹤0.01% |
342
+278
| +434% | +$32.4K |
|
3422
Aurinia Pharmaceuticals
AUPH
$2.02B
| $39.7K | ﹤0.01% |
+1,793
| New | +$28.5K |
|
|
FRBK
3423
DELISTED
Republic First Bancorp Inc
FRBK
| $39.4K | ﹤0.01% |
12,792
+5,236
| +69% | +$18.2K |
|
|
SOLY
3424
DELISTED
Soliton, Inc.
SOLY
| $39.1K | ﹤0.01% |
1,921
+1,706
| +793% | +$36.5K |
|
|
ADVM
3425
DELISTED
Adverum Biotechnologies
ADVM
| $39.1K | ﹤0.01% |
1,802
+351
| +24% | +$8.96K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2021 Portfolio in Review
As of Q3 2021, BNP Paribas Financial Markets held 4,161 positions worth $70.6B, down 6.6% from $75.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.5B in Q3 2021, closing 150 positions and reducing 1,194 holdings. Its most notable exit was GE Aerospace, an estimated $147M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares 10+ Year Investment Grade Corporate Bond ETF worth $5.86M.
- BNP Paribas Financial Markets's largest Q3 2021 buy was iShares 10+ Year Investment Grade Corporate Bond ETF: 84,600 shares worth $5.86M.
- BNP Paribas Financial Markets added most to iShares Russell 2000 ETF in Q3 2021, an estimated $615M increase.
- BNP Paribas Financial Markets's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.24B.
- BNP Paribas Financial Markets fully exited GE Aerospace in Q3 2021, selling an estimated $147M.
- BNP Paribas Financial Markets's ten largest holdings make up 14% of its $70.6B portfolio in Q3 2021.
- BNP Paribas Financial Markets opened 102 new positions and closed 150 in Q3 2021.
- BNP Paribas Financial Markets's portfolio value fell 6.6% quarter-over-quarter to $70.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.